Melatonin: Nature's most versatile biological signal?

Melatonin is a ubiquitous molecule and widely distributed in nature, with functional activity occurring in unicellular organisms, plants, fungi and animals. In most vertebrates, including humans, melatonin is synthesized primarily in the pineal gland and is regulated by the environmental light/dark cycle via the suprachiasmatic nucleus. Pinealocytes function as 'neuroendocrine transducers' to secrete melatonin during the dark phase of the light/dark cycle and, consequently, melatonin is often called the 'hormone of darkness'. Melatonin is principally secreted at night and is centrally involved in sleep regulation, as well as in a number of other cyclical bodily activities. Melatonin is exclusively involved in signaling the 'time of day' and 'time of year' (hence considered to help both clock and calendar functions) to all tissues and is thus considered to be the body's chronological pacemaker or 'Zeitgeber'. Synthesis of melatonin also occurs in other areas of the body, including the retina, the gastrointestinal tract, skin, bone marrow and in lymphocytes, from which it may influence other physiological functions through paracrine signaling. Melatonin has also been extracted from the seeds and leaves of a number of plants and its concentration in some of this material is several orders of magnitude higher than its night-time plasma value in humans. Melatonin participates in diverse physiological functions. In addition to its timekeeping functions, melatonin is an effective antioxidant which scavenges free radicals and up-regulates several antioxidant enzymes. It also has a strong antiapoptotic signaling function, an effect which it exerts even during ischemia. Melatonin's cytoprotective properties have practical implications in the treatment of neurodegenerative diseases. Melatonin also has immune-enhancing and oncostatic properties. Its 'chronobiotic' properties have been shown to have value in treating various circadian rhythm sleep disorders, such as jet lag or shift-work sleep disorder. Melatonin acting as an 'internal sleep facilitator' promotes sleep, and melatonin's sleep-facilitating properties have been found to be useful for treating insomnia symptoms in elderly and depressive patients. A recently introduced melatonin analog, agomelatine, is also efficient for the treatment of major depressive disorder and bipolar affective disorder. Melatonin's role as a 'photoperiodic molecule' in seasonal reproduction has been established in photoperiodic species, although its regulatory influence in humans remains under investigation. Taken together, this evidence implicates melatonin in a broad range of effects with a significant regulatory influence over many of the body's physiological functions.

[1]  Opher Caspi,et al.  Melatonin for the prevention and treatment of jet lag. , 2004, Alternative therapies in health and medicine.

[2]  C. Shapiro,et al.  A Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effect of Exogenous Melatonin on Delayed Sleep Phase Syndrome , 2001, Psychosomatic medicine.

[3]  D. Cardinali,et al.  Melatonin in Circadian Rhythm Sleep Disorders , 2006 .

[4]  D. Cardinali,et al.  The role of melatonin in immuno‐enhancement: potential application in cancer , 2006, International journal of experimental pathology.

[5]  R. C. Hobbs Steroid-induced fractures and bone loss in patients with asthma , 1984 .

[6]  W. Pryor,et al.  The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. , 1998, Biochemical and biophysical research communications.

[7]  P. Ylöstalo,et al.  Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. , 1988, Acta physiologica Scandinavica.

[8]  D. Tan,et al.  Melatonin as an antioxidant: physiology versus pharmacology , 2005, Journal of pineal research.

[9]  V. Srinivasan,et al.  URINARY MELATONIN IN DEPRESSION , 1983, Indian journal of psychiatry.

[10]  R. Kelly,et al.  N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. , 1984, Biochemical and biophysical research communications.

[11]  D. Kunz,et al.  Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease: an open-label pilot study using actigraphy. , 2004, Journal of clinical psychopharmacology.

[12]  M. Aktoz,et al.  Decreased nocturnal synthesis of melatonin in patients with coronary artery disease. , 2003, International journal of cardiology.

[13]  R. Reiter,et al.  Melatonin stimulates brain glutathione peroxidase activity , 1995, Neurochemistry International.

[14]  G. Migliorati,et al.  Chrono-neuroendocrinological aspects of physiological aging and senile dementia. , 1994, Chronobiologia.

[15]  M. Okawa,et al.  SUPPLEMENTARY ADMINISTRATION OF ARTIFICIAL BRIGHT LIGHT AND MELATONIN AS POTENT TREATMENT FOR DISORGANIZED CIRCADIAN REST-ACTIVITY AND DYSFUNCTIONAL AUTONOMIC AND NEUROENDOCRINE SYSTEMS IN INSTITUTIONALIZED DEMENTED ELDERLY PERSONS , 2000, Chronobiology international.

[16]  H. Manev,et al.  Early upregulation of hippocampal 5-lipoxygenase following systemic administration of kainate to rats. , 1998, Restorative neurology and neuroscience.

[17]  M. Dubocovich,et al.  Melatonin desensitizes endogenous MT2 melatonin receptors in the rat suprachiasmatic nucleus: relevance for defining the periods of sensitivity of the mammalian circadian clock to melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  M. Migaud,et al.  Melatonin and seasonal reproduction: understanding the neuroendocrine mechanisms using the sheep as a model. , 2002, Reproduction (Cambridge, England) Supplement.

[19]  G. Maestroni The immunotherapeutic potential of melatonin , 2001, Expert opinion on investigational drugs.

[20]  A. Matsumoto,et al.  Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. , 1999, Endocrinology.

[21]  A. Lewy,et al.  Melatonin shifts human circadian rhythms according to a phase-response curve. , 1992, Chronobiology international.

[22]  L. Raisz,et al.  Glucocorticoid-induced osteoporosis. , 1994, Rheumatic diseases clinics of North America.

[23]  R. Hardeland,et al.  Melatonin, a potent agent in antioxidative defense: Actions as a natural food constituent, gastrointestinal factor, drug and prodrug , 2005, Nutrition & metabolism.

[24]  R. Reiter,et al.  Melatonin and its derivatives cyclic 3‐hydroxymelatonin, N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine and 6‐methoxymelatonin reduce oxidative DNA damage induced by Fenton reagents , 2003 .

[25]  R. Reiter,et al.  N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  T. Yamada,et al.  Role of Serotonin for Scoliotic Deformity in Pinealectomized Chicken , 1997, Spine.

[27]  V. Srinivasan Melatonin, biological rhythm disorders and phototherapy. , 1997, Indian journal of physiology and pharmacology.

[28]  David R Kaplan,et al.  Neurotrophin signal transduction in the nervous system , 2000, Current Opinion in Neurobiology.

[29]  R. Silman Melatonin and the human gonadotrophin-releasing hormone pulse generator. , 1991, The Journal of endocrinology.

[30]  R. Reiter,et al.  Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction , 2003, Redox report : communications in free radical research.

[31]  R. Reiter,et al.  Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. , 1994, Life sciences.

[32]  N. Raikhlin,et al.  Melatonin and enterochromaffine cells. , 1976, Acta histochemica.

[33]  R. Reiter The pineal and its hormones in the control of reproduction in mammals. , 1980, Endocrine reviews.

[34]  C. P. Maurizi Alzheimer's disease: roles for mitochondrial damage, the hydroxyl radical, and cerebrospinal fluid deficiency of melatonin. , 2001, Medical hypotheses.

[35]  D. Blask,et al.  Putting cancer to sleep at night , 2005, Endocrine.

[36]  S. Mccormick,et al.  Effects of melatonin, its precursors and derivatives on the growth of cultured human uveal melanoma cells , 1998, Melanoma research.

[37]  L. Wetterberg,et al.  Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome , 1985, Acta psychiatrica Scandinavica.

[38]  R. Hardeland Melatonin: Multiple Functions in Signaling and Protection , 1997 .

[39]  R. Reiter,et al.  Biochemical reactivity of melatonin with reactive oxygen and nitrogen species , 2007, Cell Biochemistry and Biophysics.

[40]  M. Akbar,et al.  Melatonin: an endogenous negative modulator of 12-lipoxygenation in the rat pineal gland. , 1999, The Biochemical journal.

[41]  R. Reiter,et al.  Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with the ABTS cation radical , 2003, Journal of pineal research.

[42]  Vanesa Martín,et al.  Regulation of antioxidant enzymes: a significant role for melatonin , 2004, Journal of pineal research.

[43]  K. Kugiyama,et al.  Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. , 2001, American heart journal.

[44]  D. Cardinali,et al.  Effect of melatonin on bone metabolism in ovariectomized rats. , 2001, Life sciences.

[45]  A. Jouvet,et al.  Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets. , 1997, Life sciences.

[46]  Glenna A Dowling,et al.  Melatonin for sleep disturbances in Parkinson's disease. , 2005, Sleep medicine.

[47]  D. Cardinali,et al.  Gender‐related differences in urinary 6‐sulfatoxymelatonin levels in obese pubertal individuals , 2006, Journal of pineal research.

[48]  R. Reiter,et al.  A review of the multiple actions of melatonin on the immune system , 2005, Endocrine.

[49]  R. Reiter,et al.  DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. , 2001, The international journal of biochemistry & cell biology.

[50]  D. Pozo,et al.  The use of melatonin as a vaccine agent. , 2005, Vaccine.

[51]  John Trinder,et al.  Sick and tired: does sleep have a vital role in the immune system? , 2004, Nature Reviews Immunology.

[52]  Josep M. Guerrero,et al.  High‐affinity binding of melatonin by human circulating T lymphocytes (CD4+) , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[54]  S. Endo,et al.  Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[55]  Kiyofumi Yamada,et al.  Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. , 2005, Journal of pharmacological sciences.

[56]  Josep M. Guerrero,et al.  Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  V. Srinivasan Melatonin oxidative stress and neurodegenerative diseases. , 2002, Indian journal of experimental biology.

[58]  V. Anisimov,et al.  Melatonin and colon carcinogenesis: I. Inhibitory effect of melatonin on development of intestinal tumors induced by 1,2-dimethylhydrazine in rats. , 1997, Carcinogenesis.

[59]  D. Cardinali,et al.  Future of melatonin as a therapeutic agent. , 2002, Neuro endocrinology letters.

[60]  R. Reiter,et al.  Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light , 1998, Neurochemistry International.

[61]  A Lewinski,et al.  Anticarcinogenic actions of melatonin which involve antioxidative processes: comparison with other antioxidants. , 2001, The international journal of biochemistry & cell biology.

[62]  Koji Abe,et al.  Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.

[63]  G. Bubenik REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance , 2002, Digestive Diseases and Sciences.

[64]  Valter Tucci,et al.  Melatonin, circadian rhythms, and sleep , 2003, Current treatment options in neurology.

[65]  R. Reiter,et al.  The significance of the metabolism of the neurohormone melatonin: Antioxidative protection and formation of bioactive substances , 1993, Neuroscience & Biobehavioral Reviews.

[66]  K. Schulmeister,et al.  Melatonin and cancer risk: does light at night compromise physiologic cancer protection by lowering serum melatonin levels? , 2004, British Journal of Cancer.

[67]  J. Macher,et al.  [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders]. , 2002, L'Encephale.

[68]  L. Amzel,et al.  Structures of mammalian cytosolic quinone reductases. , 2000, Free radical biology & medicine.

[69]  R. Nelson,et al.  Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating , 2006, Brain Research Bulletin.

[70]  K J Petrie,et al.  Melatonin for the prevention and treatment of jet lag. , 2002, The Cochrane database of systematic reviews.

[71]  A. Holen,et al.  The effects of long meditation on plasma melatonin and blood serotonin. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[72]  S. Fahn,et al.  The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it , 1992, Annals of neurology.

[73]  T. Takahashi,et al.  Effect of 3 mg melatonin on jet lag syndrome in an 8‐h eastward flight , 2000, Psychiatry and clinical neurosciences.

[74]  A. Cagnacci,et al.  Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. , 1999, The American journal of cardiology.

[75]  M. Menaker,et al.  The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration , 1998, Brain Research.

[76]  J. Barrett,et al.  The oncostatic action of melatonin in an ovarian carcinoma cell line , 1999, Journal of pineal research.

[77]  L. Carlson,et al.  Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients , 2004, Psychoneuroendocrinology.

[78]  G. Maestroni,et al.  Evidence for melatonin synthesis in mouse and human bone marrow cells , 2000, Journal of pineal research.

[79]  D. Swaab,et al.  Senescence, sleep, and circadian rhythms , 2002, Ageing Research Reviews.

[80]  O. Nosjean,et al.  Identification of the Melatonin-binding SiteMT 3 as the Quinone Reductase 2* , 2000, The Journal of Biological Chemistry.

[81]  S. Markey,et al.  Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. , 1988, Archives of general psychiatry.

[82]  L. Tamarkin,et al.  Melatonin: a coordinating signal for mammalian reproduction? , 1985, Science.

[83]  J. Axelrod The pineal gland: a neurochemical transducer. , 1974, Science.

[84]  S. Checkley,et al.  The Effect of Desipramine upon Melatonin and Cortisol Secretion in Depressed and Normal Subjects , 1985, British Journal of Psychiatry.

[85]  C. Carlberg Gene Regulation by Melatonin , 2000, Annals of the New York Academy of Sciences.

[86]  E. Heist,et al.  Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects. , 1992, Archives of general psychiatry.

[87]  R. Reiter,et al.  Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages , 2005, Journal of Neuroimmunology.

[88]  Zheng Feng,et al.  Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease , 2004, Journal of pineal research.

[89]  D. Klein The 2004 Aschoff/Pittendrigh Lecture: Theory of the Origin of the Pineal Gland— A Tale of Conflict and Resolution , 2004, Journal of biological rhythms.

[90]  R. Hardeland,et al.  Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage , 2003, Journal of pineal research.

[91]  H. Manev,et al.  Circadian expression of pineal 5‐lipoxygenase mRNA , 1998, Neuroreport.

[92]  D. Cardinali,et al.  Metabolism of serotonin by the rat retina in vitro , 1971, Journal of neurochemistry.

[93]  M. Ansseau,et al.  Serum melatonin and urinary 6-sulfatoxymelatonin in major depression , 2004, Psychoneuroendocrinology.

[94]  Xiaochao Ma,et al.  METABOLISM OF MELATONIN BY HUMAN CYTOCHROMES P450 , 2005, Drug Metabolism and Disposition.

[95]  Sato Honma,et al.  Melatonin induces γ-glutamylcysteine synthetase mediated by activator protein-1 in human vascular endothelial cells , 1999 .

[96]  J. Bruce,et al.  Human pineal physiology and functional significance of melatonin , 2004, Frontiers in Neuroendocrinology.

[97]  W. Johnson,et al.  Melatonin, Sleep, and Shift Work Adaptation , 2005, Journal of occupational and environmental medicine.

[98]  D. Boivin Disturbances of Hormonal Circadian Rhythms in Shift Workers , 2006 .

[99]  D. Cardinali,et al.  Melatonin increases oestradiol‐induced bone formation in ovariectomized rats , 2003, Journal of pineal research.

[100]  O. Pignataro,et al.  Direct effect of melatonin on Syrian hamster testes: melatonin subtype 1a receptors, inhibition of androgen production, and interaction with the local corticotropin-releasing hormone system. , 2005, Endocrinology.

[101]  D. Cardinali,et al.  A multifactorial approach employing melatonin to accelerate resynchronization of sleep–wake cycle after a 12 time‐zone westerly transmeridian flight in elite soccer athletes , 2002, Journal of pineal research.

[102]  J. Atkinson,et al.  Melatonin improves cerebral circulation security margin in rats. , 1998, American journal of physiology. Heart and circulatory physiology.

[103]  J. Glass,et al.  A brain site for the antigonadal action of melatonin in the white-footed mouse (Peromyscus leucopus): involvement of the immunoreactive GnRH neuronal system. , 1987, Neuroendocrinology.

[104]  R. Hardeland,et al.  Non‐vertebrate melatonin , 2003, Journal of pineal research.

[105]  F. Scheer,et al.  Daily Nighttime Melatonin Reduces Blood Pressure in Male Patients With Essential Hypertension , 2004, Hypertension.

[106]  H. Romijn The pineal, a tranquillizing organ? , 1978, Life sciences.

[107]  J. Nurnberger,et al.  Effects of indirect light and propranolol on melatonin levels in normal human subjects , 1998, Psychiatry Research.

[108]  R. Wurtman,et al.  Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[109]  Wen‐lang Lin,et al.  Melatonin Promotes Osteoblast Differentiation and Bone Formation* , 1999, The Journal of Biological Chemistry.

[110]  Josephine Arendt,et al.  Melatonin-induced temperature suppression and its acute phase-shifting effects correlate in a dose-dependent manner in humans , 1995, Brain Research.

[111]  B. Lukert Glucocorticoid‐Induced Osteoporosis , 1992, Rheumatic diseases clinics of North America.

[112]  B. Ishizuka,et al.  Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines , 2000, Journal of pineal research.

[113]  D. Hu,et al.  Melatonin inhibits growth of cultured human uveal melanoma cells , 1997, Melanoma research.

[114]  F. Scheer Potential use of melatonin as adjunct antihypertensive therapy. , 2005, American journal of hypertension.

[115]  I. Macháčková,et al.  Melatonin in higher plants: occurrence and possible functions , 2005, Journal of pineal research.

[116]  R. Reiter,et al.  The melatonin rhythm: both a clock and a calendar , 1993, Experientia.

[117]  Zheng Feng,et al.  Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease. , 2006, Free radical biology & medicine.

[118]  M. Dubocovich,et al.  Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. , 2005, Cancer research.

[119]  M. Schemper,et al.  Serum melatonin in central precocious puberty is lower than in age-matched prepubertal children. , 1991, The Journal of clinical endocrinology and metabolism.

[120]  D. Cardinali,et al.  Melatonin and sleep in aging population , 2005, Experimental Gerontology.

[121]  D. Cardinali Nuclear receptor estrogen complex in the pineal gland. Modulation by sympathetic nerves. , 1977, Neuroendocrinology.

[122]  D. Cardinali,et al.  Does melatonin play a disease-promoting role in rheumatoid arthritis? , 2005, Journal of Neuroimmunology.

[123]  D. Shapiro Overview: clinical and physiological comparison of meditation with other self-control strategies. , 1982, The American journal of psychiatry.

[124]  Josep M. Guerrero,et al.  Melatonin reduces nitric oxide synthase activity in rat hypothalamus , 1996, Journal of pineal research.

[125]  C. Eastman,et al.  How to Trick Mother Nature into Letting You Fly Around or Stay Up All Night , 2005, Journal of biological rhythms.

[126]  G. Tosini,et al.  Localization of Aa-nat mRNA in the rat retina by fluorescence in situ hybridization and laser capture microdissection , 2004, Cell and Tissue Research.

[127]  C. Viguié,et al.  Importance of Photoperiodic Signal Quality to Entrainment of the Circannual Reproductive Rhythm of the Ewe1 , 2000, Biology of reproduction.

[128]  K. Kolaja,et al.  The role of oxidative stress in chemical carcinogenesis. , 1998, Environmental health perspectives.

[129]  P. Lavie Melatonin: Role in Gating Nocturnal Rise in Sleep Propensity , 1997, Journal of biological rhythms.

[130]  D. Dijk,et al.  Melatonin and the Circadian Regulation of Sleep Initiation, Consolidation, Structure, and the Sleep EEG , 1997, Journal of biological rhythms.

[131]  A. Matsumoto,et al.  Daily Melatonin Administration at Middle Age Suppresses Male Rate Visceral Fat, Plasma Leptin, and Plasma Insulin to Youthful Levels. , 1999, Endocrinology.

[132]  G. Maestroni,et al.  Role of the pineal gland in immunity Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone , 1986, Journal of Neuroimmunology.

[133]  C. K. Song,et al.  Seasonal Changes in Adiposity: the Roles of the Photoperiod, Melatonin and Other Hormones, and Sympathetic Nervous System , 2002, Experimental biology and medicine.

[134]  M. Sjöblom,et al.  Peripheral melatonin mediates neural stimulation of duodenal mucosal bicarbonate secretion. , 2001, The Journal of clinical investigation.

[135]  S. Cuzzocrea,et al.  Melatonin is a scavenger of peroxynitrite. , 1997, Life sciences.

[136]  R. Reiter Oxidative damage in the central nervous system: protection by melatonin , 1998, Progress in Neurobiology.

[137]  J. Rosiak,et al.  Melatonin as a hydroxyl radical scavenger , 1998, Journal of pineal research.

[138]  Vijayalaxmi,et al.  A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. , 1998, Biochemical and biophysical research communications.

[139]  S. Reppert,et al.  Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses , 1994, Neuron.

[140]  D. Cardinali,et al.  Basic aspects of melatonin action. , 1998, Sleep medicine reviews.

[141]  T. Fujita,et al.  Acute Alteration in Bone Mineral Density and Biochemical Markers for Bone Metabolism in Nephrotic Patients Receiving High-Dose Glucocorticoid and One-Cycle Etidronate Therapy , 2000, Calcified Tissue International.

[142]  J. Parkes,et al.  Delayed sleep phase syndrome response to melatonin , 1991, The Lancet.

[143]  W. Murphy,et al.  Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. , 1985, Arthritis and rheumatism.

[144]  J. Gusella,et al.  Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[145]  T. Annesley,et al.  RAPID COMMUNICATION: SERUM IMMUNOREACTIVE MELATONIN IN BOYS WITH DELAYED PUBERTY , 1982, Clinical endocrinology.

[146]  B. Vandermeer,et al.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis , 2006, BMJ : British Medical Journal.

[147]  R. Hardeland,et al.  Reactions of the melatonin metabolite AMK (N1‐acetyl‐5‐methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3‐acetamidomethyl‐6‐methoxycinnolinone and 3‐nitro‐AMK , 2005, Journal of pineal research.

[148]  P. Pévet,et al.  Contrary to other non-photic cues, acute melatonin injection does not induce immediate changes of clock gene mrna expression in the rat suprachiasmatic nuclei , 2003, Neuroscience.

[149]  R. Goodman,et al.  Neuroendocrine basis of seasonal reproduction. , 1984, Recent progress in hormone research.

[150]  D. Cardinali,et al.  Circadian organization of the immune response: A role for melatonin , 2004 .

[151]  A. Balík,et al.  Melatonin action in neonatal gonadotrophs. , 2004, Physiological research.

[152]  G. Brainard,et al.  Action Spectrum for Melatonin Regulation in Humans: Evidence for a Novel Circadian Photoreceptor , 2001, The Journal of Neuroscience.

[153]  F. Sun,et al.  Melatonin protects against MPTP/MPP+‐induced mitochondrial DNA oxidative damage in vivo and in vitro , 2005, Journal of pineal research.

[154]  R. Reiter,et al.  Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. , 1995, Biochemistry and molecular biology international.

[155]  D. Belsham,et al.  Melatonin Receptor Activation Regulates GnRH Gene Expression and Secretion in GT1–7 GnRH Neurons , 2002, The Journal of Biological Chemistry.

[156]  L Brydon,et al.  Functional expression of MT2 (Mel1b) melatonin receptors in human PAZ6 adipocytes. , 2001, Endocrinology.

[157]  R. Wurtman,et al.  Improvement of sleep quality by melatonin , 1995, The Lancet.

[158]  S. Armstrong Melatonin and circadian control in mammals , 1989, Experientia.

[159]  M. Zembala,et al.  Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects. , 1997, European journal of pharmacology.

[160]  J. L. Esparza,et al.  Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. , 2005, Free radical biology & medicine.

[161]  D. Cardinali,et al.  Melatonin in mood disorders , 2006, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[162]  Vijayalaxmi,et al.  Melatonin: from basic research to cancer treatment clinics. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[163]  M. Villareal,et al.  Osteoporosis in steroid-dependent asthma. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[164]  Trevor R. Norman,et al.  Acute increases in night-time plasma melatonin levels following a period of meditation , 2000, Biological Psychology.

[165]  R. Reiter,et al.  Melatonin mitigates mitochondrial malfunction , 2005, Journal of pineal research.

[166]  P. Brugger,et al.  The roots of meaningful coincidence , 1995, The Lancet.

[167]  E. Świętochowska,et al.  The relationship between bone metabolism, melatonin and other hormones in sham-operated and pinealectomized rats. , 2003, Endocrine regulations.

[168]  S. Carden Entrainment of Free-running Circadian Rhythms by Melatonin in Blind People, , 2001 .

[169]  P. Lavie,et al.  Seasonal Variation of Gonadotropins and Gonadal Steroids Receptors in the Human Pineal Gland , 1997, Brain Research Bulletin.

[170]  G. Maestroni,et al.  Colony-stimulating activity and hematopoietic rescue from cancer chemotherapy compounds are induced by melatonin via endogenous interleukin 4. , 1994, Cancer research.

[171]  S. Verlag Melatonin in elderly patients with insomnia A systematic review , 2001 .

[172]  W. Grünberger,et al.  A Significant Correlation between Melatonin Deficiency and Endometrial Cancer , 1998, Gynecologic and Obstetric Investigation.

[173]  Prahlad T. Ram,et al.  Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells , 2004, Breast Cancer Research and Treatment.

[174]  P. Pévet,et al.  The chronobiotic properties of melatonin , 2002, Cell and Tissue Research.

[175]  B. Poeggeler,et al.  Potent Neuroprotective Properties against the Alzheimer β-Amyloid by an Endogenous Melatonin-related Indole Structure, Indole-3-propionic Acid* , 1999, The Journal of Biological Chemistry.

[176]  B. Kos-Kudła,et al.  The influence of pinealectomy and melatonin administration on the dynamic pattern of biochemical markers of bone metabolism in experimental osteoporosis in the rat. , 2002, Neuro endocrinology letters.

[177]  D. Hakanson,et al.  Pineal and Adrenal Effects on Calcium Homeostasis in the Rat , 1990, Pediatric Research.

[178]  C. Chignell,et al.  Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. , 1997, Free radical biology & medicine.

[179]  D. Cardinali,et al.  Characterization of a cytosol progesterone receptor in bovine pineal gland. , 1979, Neuroendocrinology.

[180]  V. Anisimov,et al.  Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. , 2000, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[181]  O. Vakkuri,et al.  Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. , 1987, The Journal of clinical endocrinology and metabolism.

[182]  R. Pomerantz,et al.  Reduction of Serum Melatonin Levels in HIV-1-Infected Individuals’ Parallel Disease Progression: Correlation with Serum Interleukin-12 Levels , 2003, Infection.

[183]  T. González-Hernández,et al.  Estrogen modulation of adrenoceptor responsiveness in the female rat pineal gland: differential expression of intracellular estrogen receptors , 2004, Journal of pineal research.

[184]  R. Reiter,et al.  An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease , 2000, Journal of Neural Transmission.

[185]  S. Takeda,et al.  Prednisolone prevents decreases in trabecular bone mass and strength by reducing bone resorption and bone formation defect in adjuvant-induced arthritic rats. , 1998, Bone.

[186]  A. Carrillo-Vico,et al.  Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system , 2003, Cellular and Molecular Life Sciences CMLS.

[187]  R. Reiter,et al.  Melatonin: an antioxidant in edible plants. , 2002, Annals of the New York Academy of Sciences.

[188]  J. Vanecek,et al.  Melatonin inhibits gonadotropin-releasing hormone-induced elevation of intracellular Ca2+ in neonatal rat pituitary cells. , 1992, Endocrinology.

[189]  H. Koyama,et al.  Melatonin at Pharmacologic Doses Increases Bone Mass by Suppressing Resorption Through Down‐Regulation of the RANKL‐Mediated Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[190]  F. Hanisch Specificity Clusters of MUC1-Reactive Mouse Monoclonal Antibodies , 1997, Tumor Biology.

[191]  D. Cardinali,et al.  Low urinary 6‐sulphatoxymelatonin levels in patients with coronary artery disease , 2000, Journal of pineal research.

[192]  R. Turner,et al.  Prednisone inhibits formation of cortical bone in sham-operated and ovariectomized female rats , 1995, Calcified Tissue International.

[193]  J. Vanecek,et al.  Inhibitory effect of melatonin on gonadotropin-releasing hormone-induced Ca2+ oscillations in pituitary cells of newborn rats. , 1997, Neuroendocrinology.

[194]  S. J. Mcconnell The pineal gland and reproduction in the Tammar wallaby, Macropus eugenii , 1984 .

[195]  Yukui Zhang,et al.  Melatonin in Chinese medicinal herbs. , 2003, Life sciences.

[196]  P. Lavie,et al.  ACTIGRAPHIC SLEEP-WAKE PATTERNS AND URINARY 6-SULFATOXYMELATONIN EXCRETION IN PATIENTS WITH ALZHEIMER'S DISEASE , 2001, Chronobiology international.

[197]  R. Haque,et al.  Circadian clocks, clock networks, arylalkylamine N-acetyltransferase, and melatonin in the retina , 2005, Progress in Retinal and Eye Research.

[198]  M. Okawa,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Diminished Melatonin Secretion in the Elderly Caused by Insufficient Environmental Illumination* , 2022 .

[199]  R. Reiter,et al.  Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. , 2002, Current topics in medicinal chemistry.

[200]  R. Reiter,et al.  Melatonin‐induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo , 2000, Journal of pineal research.

[201]  D. Berson,et al.  Phototransduction by Retinal Ganglion Cells That Set the Circadian Clock , 2002, Science.

[202]  L. Wetterberg,et al.  Nocturnal melatonin secretion in thyroid disease and in obesity , 1991, Clinical endocrinology.

[203]  D. Acuña-Castroviejo,et al.  Mitochondrial regulation by melatonin and its metabolites. , 2003, Advances in experimental medicine and biology.

[204]  G. Brown,et al.  Relationship between melatonin levels in plasma and gastrointestinal tissues and the incidence and severity of gastric ulcers in pigs , 1998, Journal of pineal research.

[205]  D. Tobin,et al.  The cutaneous serotoninergic/melatoninergic system: securing a place under the sun , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[206]  R. Hardeland,et al.  Circadian Rhythms, Oxidative Stress, and Antioxidative Defense Mechanisms , 2003, Chronobiology international.

[207]  D. Cardinali,et al.  Melatonin effects on bone: experimental facts and clinical perspectives , 2003, Journal of pineal research.

[208]  D. Cardinali,et al.  Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep‐disturbed, middle‐aged, and elderly patients , 2001, Journal of pineal research.

[209]  S. Armstrong,et al.  Chronobiotics--drugs that shift rhythms. , 1996, Pharmacology & therapeutics.

[210]  S. Berga,et al.  Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. , 1988, The Journal of clinical endocrinology and metabolism.

[211]  T. Mukherjee,et al.  Antioxidant properties of melatonin: a pulse radiolysis study. , 1999, Free radical biology & medicine.

[212]  L. Grunhaus,et al.  Melatonin for the treatment of sleep disturbances in major depressive disorder. , 1998, The American journal of psychiatry.

[213]  I. Sayeed,et al.  Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti‐apoptotic effects of melatonin , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[214]  N. Gjerdet,et al.  Pinealectomy induces malformation of the spine and reduces the mechanical strength of the vertebrae in Atlantic salmon, Salmo salar , 2004, Journal of pineal research.

[215]  J. B. Martin,et al.  Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.

[216]  Bruno Claustrat,et al.  The basic physiology and pathophysiology of melatonin. , 2005, Sleep medicine reviews.

[217]  V. Anisimov Effects of Exogenous Melatonin—A Review , 2003, Toxicologic pathology.

[218]  H. Bartsch,et al.  Melatonin in cancer patients and in tumor-bearing animals. , 1999, Advances in experimental medicine and biology.

[219]  B Frangione,et al.  Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. , 2001, Biochemistry.

[220]  Irina Zhdanova,et al.  Effects of exogenous melatonin on sleep: a meta-analysis. , 2005, Sleep medicine reviews.

[221]  H. Iguichi,et al.  Age-dependent reduction in serum melatonin concentrations in healthy human subjects. , 1982, The Journal of clinical endocrinology and metabolism.

[222]  G. Kerkhof,et al.  Delayed sleep phase syndrome: A placebo‐controlled cross‐over study on the effects of melatonin administered five hours before the individual dim light melatonin onset , 1998, Journal of sleep research.

[223]  F. Herrera,et al.  Melatonin regulation of antioxidant enzyme gene expression , 2002, Cellular and Molecular Life Sciences CMLS.

[224]  M. Dubocovich,et al.  Functional MT1 and MT2 melatonin receptors in mammals , 2005, Endocrine.

[225]  G. Ferry,et al.  Molecular evidence that melatonin is enzymatically oxidized in a different manner than tryptophan: investigations with both indoleamine 2,3-dioxygenase and myeloperoxidase. , 2005, The Biochemical journal.

[226]  B. Kos-Kudła,et al.  Influence of lighting conditions on daily rhythm of bone metabolism in rats and possible involvement of melatonin and other hormones in this process. , 2003, Endocrine regulations.

[227]  M. Dubocovich,et al.  Functional Melatonin Receptors in Rat Ovaries at Various Stages of the Estrous Cycle , 2003, Journal of Pharmacology and Experimental Therapeutics.

[228]  L. Wetterberg,et al.  Melatonin production in patients with duodenal ulcer. , 2001, Neuro endocrinology letters.

[229]  C. Guilleminault,et al.  Rapid shift in peak melatonin secretion associated with improved performance in short shift work schedule. , 1997, Sleep.

[230]  M. Herold,et al.  Impaired nocturnal secretion of melatonin in coronary heart disease , 1995, The Lancet.

[231]  Josep M. Guerrero,et al.  Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. , 1997, Journal of immunology.

[232]  Prahlad T. Ram,et al.  Melatonin synergizes with retinoic acid in the prevention and regression of breast cancer. , 1999, Advances in experimental medicine and biology.

[233]  M. Turgut,et al.  Morphological, stereological and radiological changes in pinealectomized chicken cervical vertebrae , 2005, Journal of pineal research.

[234]  H. Wong,et al.  Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[235]  A. Lewy,et al.  Sleep-promoting effects of melatonin: at what dose, in whom, under what conditions, and by what mechanisms? , 1997, Sleep.

[236]  D. Garfinkel,et al.  Melatonin for treatment of sundowning in elderly persons with dementia - a preliminary study. , 2000, Archives of gerontology and geriatrics.

[237]  R. Reiter,et al.  Melatonin—A Highly Potent Endogenous Radical Scavenger and Electron Donor: New Aspects of the Oxidation Chemistry of this Indole Accessed in vitro a , 1994, Annals of the New York Academy of Sciences.

[238]  H. Korf,et al.  The rhythm and blues of gene expression in the rodent pineal gland , 2005, Endocrine.

[239]  D. Acuña-Castroviejo,et al.  Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. , 2002, The international journal of biochemistry & cell biology.

[240]  A. Strosberg,et al.  Functional Expression of MT 2 ( Mel 1 b ) Melatonin Receptors in Human PAZ 6 Adipocytes , 2001 .

[241]  A. Dosé,et al.  Melatonin's unique radical scavenging properties – roles of its functional substituents as revealed by a comparison with its structural analogs , 2002, Journal of pineal research.

[242]  J. A. Boer,et al.  Clinical efficacy of agomelatine in depression: the evidence , 2005 .

[243]  V. Srinivasan,et al.  Melatonin, immune function and aging , 2005, Immunity & Ageing.

[244]  P. Renard,et al.  Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. , 2003, Endocrinology.

[245]  J. Hébert,et al.  Meditation, melatonin and breast/prostate cancer: hypothesis and preliminary data. , 1995, Medical hypotheses.

[246]  Benita Middleton,et al.  Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans , 2004, The Journal of physiology.

[247]  P. Good,et al.  Unusual degradation of α-β complexes in Xenopus oocytes by β-subunits of Xenopus gastric H-K-ATPase. , 1998, American journal of physiology. Cell physiology.

[248]  S. Rozov,et al.  N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine is a product of melatonin oxidation in rats , 2003, Journal of pineal research.

[249]  R. Reiter,et al.  Melatonin-immune system relationships. , 2002, Current topics in medicinal chemistry.

[250]  D. Skene,et al.  Melatonin administration can entrain the free-running circadian system of blind subjects. , 2000, The Journal of endocrinology.

[251]  R. Hardeland,et al.  Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products. , 2006, Redox report : communications in free radical research.

[252]  S. Folkard,et al.  Some effects of melatonin and the control of its secretion in humans. , 2008, Ciba Foundation symposium.

[253]  D. Tobin,et al.  On the role of melatonin in skin physiology and pathology , 2005, Endocrine.

[254]  R. Reiter,et al.  Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin , 2003, Journal of pineal research.

[255]  M. Dubocovich,et al.  Melatonin mediates two distinct responses in vascular smooth muscle. , 1998, European journal of pharmacology.

[256]  G. Benítez-King Melatonin as a cytoskeletal modulator: implications for cell physiology and disease , 2006, Journal of pineal research.

[257]  R. Moore,et al.  Circadian rhythms: basic neurobiology and clinical applications. , 1997, Annual review of medicine.

[258]  Josep M. Guerrero,et al.  Reactive Oxygen Intermediates, Molecular Damage, and Aging: Relation to Melatonin , 1998, Annals of the New York Academy of Sciences.

[259]  J. Commentz,et al.  Precocious puberty and decreased melatonin secretion due to a hypothalamic hamartoma. , 1995, Hormone research.

[260]  D. Cardinali,et al.  The Use of Chronobiotics in the Resynchronization of the Sleep–wake Cycle , 2006, Cancer Causes & Control.

[261]  Cristina Bianchi,et al.  The Mitochondrial Production of Reactive Oxygen Species in Relation to Aging and Pathology , 2004, Annals of the New York Academy of Sciences.

[262]  N. Zisapel,et al.  Melatonin receptors in PC3 human prostate tumor cells , 1999, Journal of pineal research.

[263]  Josephine Arendt,et al.  Melatonin as a chronobiotic. , 2005, Sleep medicine reviews.

[264]  H. Koyama,et al.  Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro , 1999, Journal of pineal research.

[265]  D. Cardinali,et al.  Melatonin effect on bone metabolism in rats treated with methylprednisolone , 2006, Journal of pineal research.

[266]  V. Gribkoff,et al.  Molecular Dissection of Two Distinct Actions of Melatonin on the Suprachiasmatic Circadian Clock , 1997, Neuron.

[267]  D. Saur,et al.  Melatonin reduces non‐adrenergic, non‐cholinergic relaxant neurotransmission by inhibition of nitric oxide synthase activity in the gastrointestinal tract of rodents in vitro , 2002, Journal of pineal research.

[268]  M. Candito,et al.  Circadian rhythms in depression and recovery: Evidence for blunted amplitude as the main chronobiological abnormality , 1989, Psychiatry Research.

[269]  R. Liburdy,et al.  Melatonin and its precursors scavenge nitric oxide , 1999, Journal of pineal research.

[270]  F. Hirata,et al.  In vitro and in vivo formation of two new metabolites of melatonin. , 1974, The Journal of biological chemistry.

[271]  A. Cagnacci,et al.  Influences of melatonin administration on the circulation of women. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[272]  D. Pozo,et al.  Melatonin activates Th1 lymphocytes by increasing IL-12 production. , 1999, Life sciences.

[273]  D. Cardinali,et al.  Monozygotic twins with Alzheimer's disease treated with melatonin: Case report , 1998, Journal of pineal research.

[274]  I. Zhdanova,et al.  Melatonin as a hypnotic: pro. , 2005, Sleep medicine reviews.

[275]  N. Zisapel,et al.  Circadian Rhythm Sleep Disorders , 2001, CNS drugs.

[276]  C. Carlberg,et al.  Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. , 1995, Nucleic acids research.

[277]  D. Cardinali,et al.  Effect of Melatonin Treatment on 24‐h Variations in Responses to Mitogens and Lymphocyte Subset Populations in Rat Submaxillary Lymph Nodes , 2000, Journal of neuroendocrinology.

[278]  D. Cardinali,et al.  Low urinary 6-sulfatoxymelatonin levels in patients with severe congestive heart failure , 2003, Endocrine.

[279]  B. Griefahn,et al.  Excretion of 6-Hydroxymelatonin Sulfate (6-OHMS) in Siblings during Childhood and Adolescence , 2003, Neuroendocrinology.

[280]  P. Lissoni,et al.  Five years survival in metastatic non‐small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial , 2003, Journal of pineal research.

[281]  Ichiro Baba,et al.  Implication for Melatonin and Its Receptor in the Spinal Deformities of Hereditary Lordoscoliotic Rabbits , 2003, Spine.

[282]  D. Pompon,et al.  Nitrosation of melatonin by nitric oxide and peroxynitrite , 2000, Journal of pineal research.